This is the first described syndrome caused by a point mutation in codon 640 (previously 654) of the gelsolin gene (named c.640G > A or c.640G > T; chromosome 9q32-34) that results in the substitution of asparagine by aspartate at residue 187 (Asn-187). Gelsolin is an actin-modulating protein synthesized in most human tissues. Variant gelsolin expression causes an anomalous degradation product to form and manifests phenotypically as extracellular deposition of gelsolin amyloid, and causes other consequences in gelsolin metabolism and function. 2, 3, 7, 8 Normally, gelsolin permits rapid migration of cells involved in wound healing, hemostasis, and the inflammatory process 9 and prevents the toxic effects of actin. Mutations of the gelsolin gene cause familial amyloid polyneuropathy type IV. 10, 11 Clinical manifestations are late-onset, commonly appearing between the thirties and fifties, and slow progress. The earliest and most typical characteristic is type II lattice corneal dystrophy, which is no longer regarded as a dystrophy because it is caused by systemic amyloidosis. Other signs are polyneuropathy, dermatochalasis, open-angle glaucoma, bilateral progressive facial paralysis, cutis laxa, skin fragility with ecchymosis, facial mask, diffuse hair loss, dry skin, bilateral carpal tunnel syndrome, nephrotic syndrome, and cardiomyopathy with conduction alterations and early aging. 3, 4, [6] [7] [8] [11] [12] [13] [14] Corneal deposit distribution is pathognomonic, and diagnosis can be made by histological analysis after corneal transplantation or molecular diagnostic tests. 15 No specific treatment for Meretoja syndrome is currently available. Therefore, correct diagnosis only permits treatment of symptoms, including ophthalmologic, neurological, dermatological, cardiac, and renal manifestations. Plastic surgery can improve quality of life and self-esteem in affected patients.
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METHODS
We analyzed the cases of two Brazilian siblings with familial amyloid polyneuropathy type IV manifesting with dermatochalasis, bilateral facial nerve paralysis, cutis laxa, and lattice corneal dystrophy type II. These patients are of Armenian descent and do not have Finnish family history or any relatives with the syndrome. They do not have other brothers or sisters. The outcomes were measured on clinical analysis, made by assisting physician and by asking the patient about their satisfaction. No scale was used to assess satisfaction. All patients provided written consent and the study complied with the Declaration of Helsinki.
Case Reports
Case 1
A 72-year-old female patient reported onset of symptoms at age 48. She initially noticed frontal muscle palsy, evolving with conjunctival hyperemia and intermittent hemifacial spasms associated with intermittent hypophonia and numbness of the fingertips. She was subsequently diagnosed with bilateral carpal tunnel syndrome. Bilateral peripheral facial palsy presented over the course of the disease, worse on the left side and associated with mild chewing muscle palsy. Electroneuromyography showed mixed-pattern facial nerve neuropathy on both sides and significant secondary muscle denervation. Her diagnosis was established after ophthalmologic evaluation by the presence of lattice corneal dystrophy type II. By the time the patient was referred to the Eyelid and Periorbital Surgery Group at São Paulo University Medical School's Hospital das Clínicas, she had undergone three surgical procedures over a 7-year period. These procedures (bilateral cartilage grafting in the lower eyelid and left canthopexy) aimed to correct bilateral lagophtalmos were unsuccessful.
The patient presented in August 2014 with recurrence of left lagophtalmos; examination showed bilateral facial palsy classified as House-Brackmann-II on the right and III on the left side, 16 with paralytic lagophthalmos associated with negative Bell's phenomenon ( Figures 1A and  1B) . In the initial surgical procedure, we removed insufficient and malpositioned cartilage grafts, released the retractor muscles, and performed bilateral canthopexy, followed by scapha cartilage grafting as a spacer graft, because of the additional need for eyelid support. A cartilage graft was taken from the scapha of the ear with intact perichondrium on both sides, preserving a 4 mm strip of the helix. Scapha cartilage grafts were inserted through a subciliary incision and positioned on both sides in a tunnel under the orbicularis muscle, fixed to the bottom of inferior tarsal plate with two 6-0 nylon sutures perpendicularly, and supported on the arcus marginalis. The vertical dimension of the graft was shortened and adjusted allowing the eyelid margin tangent to the inferior corneal limbus. These procedures were associated with bilateral 1.4 gram gold weight implants positioned pretarsally in the upper eyelids, fixed with three 6-0 nylon sutures, and covered with temporal fascia grafts (Figures 2 and 3) . Postoperative evolution was good, with satisfactory eyelid closure on the left and slight right lagophthalmos (1 mm) and no related eye complaints at late follow up.
One year later the patient complained of sagging of left oral commissure, difficulty in speech articulation, and facial contour irregularities ( Figures 1C and 1D) . The second operation we performed was static suspension of the left mouth commissure with 2-0 nylon sutures fixed to left zygomatic arc and fat grafting of irregular facial areas secondary to paralytic dystrophy. Two years after the first surgery, the functional and aesthetic results were satisfactory and the patient had good eyelid closure, improved oral continence, and enhanced facial contour (Figures 1E and  1F ). She complained of intermittent conjunctival hyperemia, which is typical of this syndrome and regresses with eye lubricant drops.
Case 2
A 54-year-old male patient reported onset of symptoms at age 44. He initially presented with xerophthalmia and foreign body sensation in the eyes progressing to mild lagophtalmos, relapsing keratitis, frontal and corrugator muscle palsy, diminished blinking frequency, and lower eyelid dermatochalasis. Diagnosis of Meretoja syndrome was confirmed by lattice corneal dystrophy type II during ophthalmologic screening; this patient's clinical manifestations were less severe than those experienced by his sister (described above).
The patient did not receive treatment prior to appearing at our institution in August 2014. Examination revealed symmetric bilateral facial palsy classified as House-Brackmann II, in addition to the symptoms mentioned above ( Figures 4A and 4B ). We performed bilateral canthopexy and lower blepharoplasty using the skin flap technique. At the two year follow up, the patient was satisfied, showed good eyelid closure, and enhanced lower eyelid aesthetics as a result of this procedure ( Figures 4C  and 4D ). This patient, however, complained of intermittent keratitis and the sporadic need for eye lubricant drops during the day and gel during the night.
DISCUSSION
The pathophysiology of Meretoja syndrome is not fully understood. Nonetheless, it is hypothesized the disease involves both impaired nerve lesion recovery due to a lack of normal gelsolin function and buildup of amyloid peptides derived from variant gelsolin degradation on the basal membranes, arterioles, nerves, skin appendages, and elastic fibers, consequently modifying the function of these components. 10 Release of the retractor muscles, canthopexy, lower eyelid cartilage grafting, and most notably gold weight implants improved eyelid closure and provided significant ocular comfort in the cases reported. The gold weight is protected with a temporal fascia cover intended to reduce the visibility of the weight by preventing a transition from the submuscular to the subcutaneous plane. Lower blepharoplasty enhanced lower eyelid aesthetics by removing excess skin and fat grafting helped soften facial contour irregularities.
Suspicion and diagnosis of this syndrome most commonly occur during ophthalmologic consultation, because the first symptoms affect the eye as a result of corneal dystrophy starting during the third decade. 15, 17 In the first case reported here, an ophthalmologist made the diagnosis by observing the pathognomonic lattice corneal dystrophy type II. Molecular testing is not essential for diagnosis, but future availability will further assist in completing and expanding the recognition of this syndrome. 10, 18 As the disease progresses, during the fifth decade of life patients may exhibit paralysis with loss of facial expression, sagging skin, xerophthalmia, recurrent keratitis, and even corneal ulcers, hair loss, and dry skin. 8, [10] [11] [12] 15 Facial palsy first affects the frontal branches and then progresses to lower branches, presenting axonal electrophysiological alteration and unusual conduction block, as seen in our previous cases. 10 In these cases, plastic surgery plays a significant role in functional and cosmetic treatment of the disease. The goals for the plastic surgeon should include adequate eyelid closure, dermatochalasis treatment, good oral continence and chewing, correction of facial contour irregularities, and reducing the psychosocial burden of facial palsy and early aging. Because of systemic nerve injury, reconstruction with innervated flaps or nerve decompression is not successful. As a result, static procedures should be indicated 10 ; these include facial suspension, as described by Blair, 19 canthopexy, perioral suspension or partial lip resections, and auricular cartilage grafts for lower eyelid support. The goal of this last procedure is to elevate the lower eyelid, forcing it to remain in a position tangent to the lower limbus. 8, 20, 21 Scapha cartilage grafting to help elevate the lower eyelid is reserved for patients with need for additional lower lid support to treat malposition, as seen in case 2. In addition to gold weight implants and canthopexy, that procedure represents our choice in moderate and severe cases of lagophtalmos, because vertical length of the lower eyelid is not restored with procedures to the lateral canthus only.
Patients with Meretoja syndrome present with very different clinical expressions ranging from early aging or mild lagophtalmos to total facial paralysis, with many different types and quantities of surgical procedures required to relieve symptoms. In our cases, up to four procedures were needed, which is similar to findings by Pihlamaa et al showing cases requiring six procedures. These authors suggest that the rapid progression of the disease with short-term surgical results is the reason why multiple procedures are necessary. 10 Limitations of this study include the small number of patients as the disease is rare and the short-term results due to disease progression. Also, the outcome and satisfaction assessment was performed by an assisting physician, which could cause a confirmation bias. In future studies, using standardized tools for outcome assessment would be more reliable. Nonetheless, this study shows good results with surgical treatment and helps clarify and spread the details of Meretoja syndrome and the importance of plastic surgery by improving patients' functional and aesthetic limitations.
CONCLUSION
We conclude that plastic surgery plays an important role in the symptomatic treatment of Meretoja syndrome. Operative treatment should be individually planned to address each patient's functional and aesthetic deficits, sometimes requiring many operations to achieve good results. 
